Robert Morlock , Partner

Robert Morlock is an experienced health care organization leader with over 16 years progressive experience in the U.S. and international markets. He has executive level experience overseeing country launch teams, named patient programs, and reimbursement and access planning. He has worked in all stages of product development and has been instrumental in establishing commercialization strategies bringing novel therapies to market.

Dr. Morlock joined Pharmacision in 2011 and specializes in market access and reimbursement, health services research, patient reported outcomes, and pricing. Dr. Morlock established the pricing practice at i3 Innovus and led a biologics observational research team.  Robert also directed a team of pharmacoeconomic and outcomes researchers at Pfizer, Inc., led the oncology and rheumatology global health economics function for Biogen Idec and was Vice President of Pricing and Market Access at Abraxis BioScience. In addition, Dr. Morlock worked as a researcher at Henry Ford Health System where he led several retrospective and prospective outcomes studies in a variety of disease areas.

Robert has a PhD in economics from Wayne State University and continuing executive training from Harvard University School of Public Health and the University of Michigan Business School.